N22108
yw32h01.s1 Morton Fetal Cochlea Homo sapiens cDNA clone IMAGE:253969 3' similar to gb:X13238 CYTOCHROME C OXIDASE POLYPEPTIDE VIC PRECURSOR (HUMAN), mRNA sequence.
427
mRNA
Homo sapiens
DL031122
JP 2005512499-A/22108: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
573
DNA
synthetic construct
DJ952469
JP 2010500568-A/39150: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE.
730
PRT
Homo sapiens
DJ151488
JP 2007228956-A/22106: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
HV878649
JP 2010507387-A/22060: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
LF829264
JP 2016528161-A/22097: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
HZ526889
JP 2016501039-A/22108: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
MD268241
JP 2020517247-A/22108: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
DD548711
JP 2004508801-A/22108: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
OG658494
JP 2021500321-A/22108: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
PD710022
JP 2021530475-A/22104: De novo Design of Protein Switches.
56
PRT
synthetic construct
LF681329
JP 2016521556-A/22108: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
LV567930
JP 2017029159-A/22108: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PA526592
JP 2022502046-A/9374: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DL903852
JP 2014205669-A/22108: Method of constructing and screening libraries of peptide structures.
29
PRT
synthetic construct
MC550608
JP 2019525738-A/22108: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
9
PRT
synthetic construct
MC774218
JP 2018525446-A/22108: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
33
PRT
synthetic construct
MB811366
JP 2019502674-A/22108: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
43
PRT
synthetic construct
MB763270
JP 2018535655-A/27167: ASGR INHIBITORS.
9
PRT
synthetic construct
MD754350
JP 2019507579-A/22108: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
FU796589
JP 2009528046-A/22106: Method for identifying useful proteins of brewery yeast.
25
DNA
Saccharomyces pastorianus
PA337756
JP 2021522188-A/22108: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
DJ525908
JP 2010517930-A/22108: Method of constructing and screening libraries of peptide structures.
29
PRT
synthetic construct
DM758802
JP 2014079248-A/22108: NEISSERIAL ANTIGENIC PEPTIDES.
7
PRT
Neisseria
MC163952
JP 2019500349-A/22108: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
HW187136
JP 2013102767-A/22060: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
HW857332
JP 2015051004-A/22060: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
PA392831
JP 2021533803-A/21914: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
LX119724
JP 2017506877-A/22106: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
OG751627
JP 2021120380-A/22108: CANCER NEOEPITOPES.
9
PRT
Homo sapiens